These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 15525795)
1. YC-1 [3-(5'-Hydroxymethyl-2'-furyl)-1-benzyl Indazole] exhibits a novel antiproliferative effect and arrests the cell cycle in G0-G1 in human hepatocellular carcinoma cells. Wang SW; Pan SL; Guh JH; Chen HL; Huang DM; Chang YL; Kuo SC; Lee FY; Teng CM J Pharmacol Exp Ther; 2005 Mar; 312(3):917-25. PubMed ID: 15525795 [TBL] [Abstract][Full Text] [Related]
2. YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor. Chiang WC; Teng CM; Lin SL; Chen YM; Tsai TJ; Hsieh BS Eur J Pharmacol; 2005 Jul; 517(1-2):1-10. PubMed ID: 15950964 [TBL] [Abstract][Full Text] [Related]
4. FTY720 induces apoptosis of human hepatoma cell lines through PI3-K-mediated Akt dephosphorylation. Lee TK; Man K; Ho JW; Sun CK; Ng KT; Wang XH; Wong YC; Ng IO; Xu R; Fan ST Carcinogenesis; 2004 Dec; 25(12):2397-405. PubMed ID: 15297371 [TBL] [Abstract][Full Text] [Related]
5. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells. Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451 [TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1). Patel V; Lahusen T; Leethanakul C; Igishi T; Kremer M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS; Senderowicz AM Clin Cancer Res; 2002 Nov; 8(11):3549-60. PubMed ID: 12429646 [TBL] [Abstract][Full Text] [Related]
7. Cell cycle kinase inhibitor expression and hypoxia-induced cell cycle arrest in human cancer cell lines. Box AH; Demetrick DJ Carcinogenesis; 2004 Dec; 25(12):2325-35. PubMed ID: 15347600 [TBL] [Abstract][Full Text] [Related]
8. YC-1-induced cyclooxygenase-2 expression is mediated by cGMP-dependent activations of Ras, phosphoinositide-3-OH-kinase, Akt, and nuclear factor-kappaB in human pulmonary epithelial cells. Chang MS; Lee WS; Chen BC; Sheu JR; Lin CH Mol Pharmacol; 2004 Sep; 66(3):561-71. PubMed ID: 15322248 [TBL] [Abstract][Full Text] [Related]
9. YC-1 inhibits proliferation of human vascular endothelial cells through a cyclic GMP-independent pathway. Hsu HK; Juan SH; Ho PY; Liang YC; Lin CH; Teng CM; Lee WS Biochem Pharmacol; 2003 Jul; 66(2):263-71. PubMed ID: 12826268 [TBL] [Abstract][Full Text] [Related]
10. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function. Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267 [TBL] [Abstract][Full Text] [Related]
11. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells. Hsu SL; Hsu JW; Liu MC; Chen LY; Chang CD Exp Cell Res; 2000 Aug; 258(2):322-31. PubMed ID: 10896783 [TBL] [Abstract][Full Text] [Related]
12. Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells. Di Gennaro E; Barbarino M; Bruzzese F; De Lorenzo S; Caraglia M; Abbruzzese A; Avallone A; Comella P; Caponigro F; Pepe S; Budillon A J Cell Physiol; 2003 Apr; 195(1):139-50. PubMed ID: 12599217 [TBL] [Abstract][Full Text] [Related]
13. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines. Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate. Liang YC; Lin-Shiau SY; Chen CF; Lin JK J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699 [TBL] [Abstract][Full Text] [Related]
15. UCN-01-induced cell cycle arrest requires the transcriptional induction of p21(waf1/cip1) by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway. Facchinetti MM; De Siervi A; Toskos D; Senderowicz AM Cancer Res; 2004 May; 64(10):3629-37. PubMed ID: 15150122 [TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism of cell cycle blockage of hepatoma SK-Hep-1 cells by Epimedin C through suppression of mitogen-activated protein kinase activation and increased expression of CDK inhibitors p21(Cip1) and p27(Kip1). Liu TZ; Chen CY; Yiin SJ; Chen CH; Cheng JT; Shih MK; Wang YS; Chern CL Food Chem Toxicol; 2006 Feb; 44(2):227-35. PubMed ID: 16112786 [TBL] [Abstract][Full Text] [Related]
18. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53. Rao S; Lowe M; Herliczek TW; Keyomarsi K Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471 [TBL] [Abstract][Full Text] [Related]
19. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells. Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818 [TBL] [Abstract][Full Text] [Related]
20. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein. Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]